Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Oct
20
2021
US Regulatory Considerations Applicable to Digital Health Providers and Suppliers - Part III: FDCA K&L Gates
Oct
19
2021
ANSES Publishes Health Risk Assessment Guide for Nanomaterials in Food Bergeson & Campbell, P.C.
Oct
19
2021
California’s Senate Bill 41: The Genetic Information Privacy Act Mintz
Oct
19
2021
California and Florida Introduce Two More Genetic Privacy Laws Into the Mix Womble Bond Dickinson (US) LLP
Oct
19
2021
Godiva to Settle Geographical Claim Dispute Keller and Heckman LLP
Oct
19
2021
Update Regarding US COVID-19 Travel Restrictions Squire Patton Boggs (US) LLP
Oct
19
2021
USDA Announces Plan to Prepare for Climate Change Keller and Heckman LLP
Oct
18
2021
California Broadens Security and Breach Laws, Includes Genetic Data Sheppard, Mullin, Richter & Hampton LLP
Oct
18
2021
Proposed Settlement in ‘Belgium 1926’ Class Action Keller and Heckman LLP
Oct
18
2021
Prop 65 Regulatory Update for the Food & Cannabis Industry: OEHHA Proposes Specialized Warnings for Exposures to Acrylamide from Food & Exposures to Smoke from Cannabis/THC Products Squire Patton Boggs (US) LLP
Oct
16
2021
CareDx v. Natera – Are Processing Steps Known to the Art Always “Conventional”? Schwegman, Lundberg & Woessner, P.A.
Oct
15
2021
McDermottPlus Check-Up: October 15, 2021 McDermott Will & Emery
Oct
15
2021
COVID-19 Travel Restrictions Set to Relax for Fully Vaccinated Jackson Lewis P.C.
Oct
15
2021
Delta-8 THC: More Risk than Reward Ward and Smith, P.A.
Oct
15
2021
FDA Withdrawing Temporary Policies for Non-Drug Manufacturers Producing Hand Sanitizer Products During the COVID-19 Public Health Emergency Womble Bond Dickinson (US) LLP
Oct
14
2021
FDA Begins Modernizing its Resources and Implementing Over-The-Counter Monograph User Fee Requirements Mintz
Oct
14
2021
FDA Issues Guidance on Voluntary Sodium Reduction Keller and Heckman LLP
Oct
14
2021
EC Standing Committee Approves EC Proposal to Ban Use of Titanium Dioxide (E171) as a Food Additive Bergeson & Campbell, P.C.
Oct
13
2021
Ninth Edition of GHS Includes Revisions to Chapter 2.1 (Explosives) and Decision Logic Bergeson & Campbell, P.C.
Oct
13
2021
FDA Enters Food Safety Agreements with Four States Keller and Heckman LLP
Oct
13
2021
To North Carolina Governmental Employers: Heads-Up – "Unreasonable Employee Discipline" Can Now Get You Sued Ward and Smith, P.A.
Oct
12
2021
PhRMA Code Revisions To Go Into Effect January 2022 McDermott Will & Emery
Oct
12
2021
NNCO Releases 2021 NNI Strategic Plan Bergeson & Campbell, P.C.
Oct
12
2021
Florida’s Protecting DNA Privacy Act Goes into Effect Hunton Andrews Kurth
Oct
12
2021
Coverage of FDA’s AI/ML Medical Devices Workshop - Part 2: FDA’s Recent Digital Health Initiatives Mintz
Oct
12
2021
Texas Governor Issues Executive Order Aimed at Prohibiting Vaccine Mandates for Private Employers Proskauer Rose LLP
Oct
12
2021
California Passes Hemp Bill into Law Keller and Heckman LLP
Oct
12
2021
California Cannabis Shop Wins 15M at Industry's First Antitrust Trial MoginRubin
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins